US Stock MarketDetailed Quotes

ADAP Adaptimmune Therapeutics

Watchlist
  • 1.250
  • +0.005+0.41%
Trading Jul 16 14:54 ET
319.48MMarket Cap-1721P/E (TTM)

Adaptimmune Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2024/Q1
Stock NameRevenueRatio
Development revenue5.68M100.00%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United Kingdom (U.K.)60.28M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept CAR-T Therapy
CAR-T Therapy
Intraday+0.88%